Entity usage

Showing below up to 50 results in range #1 to #50.

1. A Bayesian method for estimating gene‐level polygenicity under the framework of transcriptome‐wide association study: Label: en
2. Frequentist analysis of basket trials with one‐sample Mantel‐Haenszel procedures: Label: en
3. A Bayesian multistage spatio‐temporally dependent model for spatial clustering and variable selection: Label: en
4. A latent functional approach for modeling the effects of multidimensional exposures on disease risk: Label: en
5. Analysis of secondary failure time responses in studies with response‐dependent sampling schemes: Label: en
6. Handling missing within‐study correlations in the evaluation of surrogate endpoints: Label: en
7. Correcting prevalence estimation for biased sampling with testing errors: Label: en
8. Comparison of combination methods to create calibrated ensemble forecasts for seasonal influenza in the U.S.: Label: en
9. Subgroup analysis using Bernoulli‐gated hierarchical mixtures of experts models: Label: en
10. Detection of sparse differential dependent functional brain connectivity: Label: en
11. Change point detection for high dimensional data via kernel measure with application to human aging brain data: Label: en
12. A flexible quasi‐likelihood model for microbiome abundance count data: Label: en
13. A threshold longitudinal Tobit quantile regression model for identification of treatment‐sensitive subgroups based on interval‐bounded longitudinal measurements and a continuous covariate: Label: en
14. Approximate likelihood and pseudo‐likelihood inference in meta‐analysis of diagnostic accuracy studies accounting for disease prevalence and study design: Label: en
15. Selection of a statistical analysis method for the Glasgow Outcome Scale‐Extended endpoint for estimating the probability of favorable outcome in future severe <scp>TBI</scp> clinical trials: Label: en
16. Clustering of trajectories with mixed effects classification model: Inference taking into account classification uncertainties: Label: en
17. Maximum approximate likelihood estimation in accelerated failure time model for interval‐censored data: Label: en
18. Shrinkage estimators of the spatial relative risk function: Label: en
19. Estimation of the time of exposure based on interval and censored data using the ε‐accelerated EM algorithm: Label: en
20. Confidence intervals for the Cox model test error from cross‐validation: Label: en
21. Bayesian design and analysis of two‐arm cluster randomized trials using assurance: Label: en
22. Measuring the performance of prediction models to personalize treatment choice: Defining observed and predicted pairwise treatment effects: Label: en
23. A guide to regression discontinuity designs in medical applications: Label: en
24. Forecasting emergency department waiting time using a state space representation: Label: en
25. Semiparametric probit regression model with misclassified current status data: Label: en
26. Federated causal inference in heterogeneous observational data: Label: en
27. A comparison of Bayesian information borrowing methods in basket trials and a novel proposal of modified exchangeability‐nonexchangeability method: Label: en
28. Simple Bayesian models for missing binary outcomes in randomized controlled trials: Label: en
29. Instrumental variable analysis for cost outcome: Application to the effect of primary care visit on medical cost among low‐income adults: Label: en
30. Rank intraclass correlation for clustered data: Label: en
31. Estimation of conditional power in the presence of auxiliary data: Label: en
32. Unified semicompeting risks analysis of hepatitis natural history through mediation modeling: Label: en
33. Risk ratio and rate ratio estimation in case‐cohort designs: Hypertension and cardiovascular mortality: Label: en
34. Assessing potentially time‐dependent treatment effect from clinical trials and observational studies for survival data, with applications to the Women's Health Initiative combined hormone therapy trial: Label: en
35. A MEASURE OF ASSOCIATION FOR ASSESSING PREDICTION ACCURACY THAT IS A GENERALIZATION OF NON-PARAMETRIC ROC AREA: Label: en
36. Sample size formula for a win ratio endpoint: Label: en
37. Modeling and validating Bayesian accrual models on clinical data and simulations using adaptive priors: Label: en
38. Predicting accrual in clinical trials with Bayesian posterior predictive distributions: Label: en
39. Sample size calculations for ordered categorical data: Label: en
40. Sample size calculations with compliance information: Label: en
41. Graphical calibration curves and the integrated calibration index (ICI) for survival models: Label: en
42. The Integrated Calibration Index (ICI) and related metrics for quantifying the calibration of logistic regression models: Label: en
43. Randomization inference for treatment effects on a binary outcome: Label: en
44. Sample size considerations for micro‐randomized trials with binary proximal outcomes: Label: en
45. Utility‐based optimization of phase II/III programs: Label: en
46. Rank intraclass correlation for clustered data: Label: en
47. A longitudinal transition imputation model for categorical data applied to a large registry dataset: Label: en
48. Minimum sample size for external validation of a clinical prediction model with a binary outcome: Label: en
49. Minimum sample size for external validation of a clinical prediction model with a continuous outcome: Label: en
50. L 1 penalized continuation ratio models for ordinal response prediction using high‐dimensional datasets: Label: en